vomiting on glp-1 Frontiers Throwing Up on a GLP-1:

Some individuals may experience mild discomfort, swelling or redness at the injection site

The broader picture is one in which MOTS-c addresses a gap that many other longevity interventions leave unfilled: the mitochondrial signaling decline that is simultaneously a cause and consequence of metabolic aging

Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist for type 2 diabetes and weight management, which works by suppressing appetite, slowing gastric emptying, increasing feelings of fullness, and reducing calorie intake

Antioxidative enzymes like GPx and SOD, however, tend to be dependent on the state of CD as well as the serum level

This piece is about which one is, and why the answer matters beyond a single peptide